Takashi Tsuboi Selected Research

Takashi Tsuboi Research Topics

Disease

18	Parkinson Disease (Parkinson's Disease) 06/2022 - 05/2015
14	Schizophrenia (Dementia Praecox) 10/2022 - 06/2011
6	Major Depressive Disorder (Major Depressive Disorders) 03/2022 - 01/2017
6	Dystonia (Limb Dystonia) 01/2021 - 01/2019
4	Essential Tremor (Essential Tremors) 09/2021 - 10/2020
4	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 01/2020
4	Speech Disorders (Cluttering) 01/2020 - 05/2015
3	Mania (Manias) 01/2022 - 11/2020
3	Tremor (Tremors) 01/2021 - 01/2020
3	Dysarthria (Spastic Dysarthria) 01/2020 - 12/2017
3	Voice Disorders (Voice Disturbances) 12/2017 - 08/2015
2	Treatment-Resistant Schizophrenia 10/2022 - 01/2022
2	Pain (Aches) 06/2022 - 05/2020
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2021
2	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 08/2016
2	Sudden Infant Death (SID) 01/2021 - 01/2019
2	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 12/2016
2	Stuttering (Stammering) 06/2019 - 12/2017
2	Disease Progression 01/2018 - 01/2013
2	Hypersensitivity (Allergy) 01/2013 - 01/2010
2	Insulinoma 04/2006 - 04/2003
1	Fatigue 06/2022
1	COVID-19 06/2022
1	Myocarditis (Carditis) 06/2022
1	Pericarditis 06/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Dyskinesias (Dyskinesia) 01/2021
1	Body Weight (Weight, Body) 11/2020
1	Prodromal Symptoms 05/2020
1	Torticollis (Wryneck) 05/2020
1	Dystonia musculorum deformans type 1 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Hemorrhage 01/2020
1	Substance-Related Disorders (Drug Abuse) 01/2020
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 12/2019
1	Mood Disorders (Mood Disorder) 10/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	X-Linked Bulbo-Spinal Atrophy 01/2018
1	Autism Spectrum Disorder 01/2018
1	Multiple Sclerosis 12/2016
1	Pathologic Complete Response 12/2016
1	Darier Disease (Darier's Disease) 08/2016
1	Hyperprolactinemia 08/2013
1	Cataract (Cataracts) 10/2012
1	Uveitis 10/2012
1	Dental Caries (Decay, Dental) 08/2012

Drug/Important Bio-Agent (IBA)

9	Antipsychotic Agents (Antipsychotics)IBA 10/2022 - 06/2011
6	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2020
4	Risperidone (Risperdal Consta)FDA LinkGeneric 09/2021 - 04/2012
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2022 - 01/2011
3	Olanzapine (Zyprexa)FDA Link 09/2021 - 04/2012
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 08/2013 - 04/2012
2	Clozapine (Clozaril)FDA LinkGeneric 10/2022 - 01/2022
2	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 09/2021
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022 - 09/2021
2	CalciumIBA 01/2021 - 08/2016
2	LithiumIBA 11/2020 - 01/2020
2	Dopamine (Intropin)FDA LinkGeneric 12/2019 - 05/2015
2	Biological ProductsIBA 01/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2013
2	enhanced green fluorescent proteinIBA 04/2006 - 04/2003
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2006 - 04/2003
1	Monoamine Oxidase (MAO)IBA 06/2022
1	VaccinesIBA 06/2022
1	N-acetyltryptophanamide (NATA)IBA 03/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	SDMIBA 01/2022
1	blonanserinIBA 09/2021
1	Quetiapine Fumarate (Seroquel)FDA Link 09/2021
1	Aripiprazole (Abilify)FDA Link 09/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	Carbamazepine (Tegretol)FDA LinkGeneric 11/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2020
1	Lamotrigine (Lamictal)FDA LinkGeneric 11/2020
1	LDL CholesterolIBA 05/2020
1	Hemoglobins (Hemoglobin)IBA 05/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 05/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	SteroidsIBA 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 06/2019
1	CreatinineIBA 01/2018
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 12/2016
1	Initiator Codon (Start Codon)IBA 08/2016
1	Codon (Codons)IBA 08/2016
1	Adenosine Triphosphatases (ATPase)IBA 08/2016
1	ProlactinIBA 08/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	Sirolimus (Rapamycin)FDA Link 10/2012

Therapy/Procedure

25	Deep Brain Stimulation 12/2021 - 05/2015
5	Therapeutics 01/2020 - 12/2016
3	Polypharmacy 03/2022 - 01/2021
2	Activities of Daily Living (ADL) 10/2020 - 06/2019
1	Drug Therapy (Chemotherapy) 03/2022
1	Occupational Therapy (Therapy, Occupational) 01/2021
1	Length of Stay 01/2020
1	Oral Diagnosis (Oral Examination) 08/2012
1	Injections 08/2012